SCN2A and epilepsy: Specifically, evidence from in vitro functional evaluation of SCN2A variants supported the hypothesis that loss-of-function (LoF) variants were the drivers of ASD/ID, whereas GoF variants caused early-onset epilepsy (Ben-Shalom et al., 2017).